Future directions in the prevention of prostate cancer

Ian M. Thompson, April B. Cabang, Michael J. Wargovich

Resultado de la investigación: Review articlerevisión exhaustiva

34 Citas (Scopus)


The high global incidence of prostate cancer has led to a focus on chemoprevention strategies to reduce the public health impact of the disease. Early studies indicating that selenium and vitamin E might protect against prostate cancer encouraged large-scale studies that produced mixed clinical results. Next-generation prostate cancer prevention trials validated the impact of 5α-reductase inhibitors in hormone-responsive prostate cancer, and these results were confirmed in follow-up studies. Other interventions on the horizon, involving both dietary and pharmacological agents, hold some promise but require further investigation to validate their efficacy. In this Review, we discuss the clinical and preclinical evidence for dietary and pharmacological prevention of prostate cancer and give an overview of future opportunities for chemoprevention.

Idioma originalEnglish (US)
Páginas (desde-hasta)49-60
Número de páginas12
PublicaciónNature Reviews Clinical Oncology
EstadoPublished - ene 2014

ASJC Scopus subject areas

  • Oncology


Profundice en los temas de investigación de 'Future directions in the prevention of prostate cancer'. En conjunto forman una huella única.

Citar esto